Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cerebral Hemorrhage | 6 | 2018 | 820 | 2.38 | Why? |
| Stroke | 17 | 2021 | 8839 | 1.44 | Why? |
| Sinus Thrombosis, Intracranial | 3 | 2021 | 550 | 1.24 | Why? |
| Intracranial Hemorrhages | 6 | 2021 | 1170 | 1.17 | Why? |
| Brain Ischemia | 9 | 2020 | 2813 | 1.02 | Why? |
| Mammillary Bodies | 1 | 2016 | 1 | 0.69 | Why? |
| Amnesia | 1 | 2016 | 18 | 0.68 | Why? |
| Fibrinolytic Agents | 3 | 2018 | 1702 | 0.67 | Why? |
| Thrombolytic Therapy | 9 | 2021 | 2218 | 0.61 | Why? |
| Brain Infarction | 1 | 2016 | 129 | 0.59 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 317 | 0.56 | Why? |
| Tissue Plasminogen Activator | 2 | 2017 | 778 | 0.51 | Why? |
| Health Status Disparities | 2 | 2020 | 4072 | 0.44 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2017 | 665 | 0.41 | Why? |
| Magnetic Resonance Imaging | 8 | 2021 | 6551 | 0.39 | Why? |
| African Americans | 2 | 2018 | 3363 | 0.30 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.30 | Why? |
| Hospital Mortality | 6 | 2021 | 22087 | 0.26 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.22 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.20 | Why? |
| Cerebrovascular Disorders | 2 | 2018 | 1040 | 0.20 | Why? |
| Interrupted Time Series Analysis | 2 | 2020 | 868 | 0.20 | Why? |
| Thrombectomy | 3 | 2021 | 2272 | 0.20 | Why? |
| Administration, Intravenous | 3 | 2018 | 1115 | 0.19 | Why? |
| Tertiary Care Centers | 4 | 2020 | 8248 | 0.18 | Why? |
| Magnetic Resonance Angiography | 2 | 2016 | 282 | 0.18 | Why? |
| Tennessee | 1 | 2018 | 243 | 0.17 | Why? |
| Treatment Outcome | 11 | 2021 | 51732 | 0.17 | Why? |
| Disability Evaluation | 2 | 2018 | 671 | 0.17 | Why? |
| Craniotomy | 1 | 2018 | 123 | 0.17 | Why? |
| Mechanical Thrombolysis | 1 | 2018 | 150 | 0.17 | Why? |
| Platelet Aggregation Inhibitors | 2 | 2018 | 1671 | 0.16 | Why? |
| Contraindications, Drug | 1 | 2018 | 281 | 0.16 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.16 | Why? |
| Aged | 16 | 2021 | 215776 | 0.16 | Why? |
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 98 | 0.16 | Why? |
| Infarction, Middle Cerebral Artery | 1 | 2018 | 203 | 0.15 | Why? |
| Male | 19 | 2021 | 367725 | 0.15 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.15 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.14 | Why? |
| Central Nervous System Diseases | 1 | 2020 | 410 | 0.14 | Why? |
| Geography | 1 | 2021 | 1801 | 0.14 | Why? |
| Female | 18 | 2021 | 380317 | 0.14 | Why? |
| Natural Language Processing | 1 | 2018 | 436 | 0.13 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.13 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.13 | Why? |
| Time Factors | 5 | 2020 | 31397 | 0.13 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2018 | 436 | 0.13 | Why? |
| Health Expenditures | 1 | 2021 | 904 | 0.13 | Why? |
| Humans | 31 | 2021 | 930598 | 0.12 | Why? |
| Time-to-Treatment | 2 | 2020 | 5883 | 0.11 | Why? |
| Greece | 1 | 2018 | 2091 | 0.11 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.10 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.10 | Why? |
| Intracranial Aneurysm | 1 | 2015 | 504 | 0.10 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.10 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.09 | Why? |
| Risk | 1 | 2021 | 5288 | 0.09 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.09 | Why? |
| United States | 4 | 2020 | 46150 | 0.09 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.09 | Why? |
| Adult | 7 | 2021 | 244371 | 0.09 | Why? |
| International Cooperation | 1 | 2021 | 3436 | 0.08 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.08 | Why? |
| Databases, Bibliographic | 2 | 2018 | 182 | 0.08 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.08 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.08 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.08 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.07 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.07 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Electrocardiography | 1 | 2018 | 3957 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Brain | 1 | 2021 | 5133 | 0.06 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.06 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Amlodipine | 1 | 2021 | 45 | 0.06 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.06 | Why? |
| Losartan | 1 | 2021 | 86 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.05 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Reperfusion | 1 | 2017 | 491 | 0.04 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Cerebral Angiography | 1 | 2015 | 391 | 0.03 | Why? |
| Neuroimaging | 1 | 2021 | 1106 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Endovascular Procedures | 1 | 2021 | 1302 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.03 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.03 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.02 | Why? |
| Blood Pressure | 1 | 2021 | 2198 | 0.02 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2021 | 1962 | 0.02 | Why? |
| Meta-Analysis as Topic | 1 | 2015 | 1289 | 0.02 | Why? |
| Research | 1 | 2021 | 2115 | 0.02 | Why? |
| Iran | 1 | 2020 | 5467 | 0.02 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Cohort Studies | 1 | 2015 | 36005 | 0.01 | Why? |
Zand's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(298)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_